1/9/2026Hengrui Secures China Approval for Retlirafusp Alfa for Gastric Cancer

1/8/2026BMS/Biokin's ADC Hits Phase III Milestone in Advanced NPC

1/8/2026Hansoh Wins Fifth China Approval for Flagship Lung Cancer Drug Ameile

1/8/2026Luye's Ruoxinlin NDA Accepted in China for Anxiety Disorder Treatment

1/8/2026Hengrui Wins China Approval for Retlirafusp Alfa

1/8/2026HUTCHMED Reports Positive Phase III Results for Sovleplenib in China

1/8/2026AskBio Receives FDA Acceptance of IND for AB-1009 Gene Therapy

1/8/2026Curium's IND for 177Lu-PSMA-I&T Accepted for Review in China

1/8/2026Alumis Reports Positive Phase 3 Results for Envudeucitinib in Plaque P...

1/7/2026NovaBridge Reports Encouraging Early Data for Givastomig Combo

1/7/2026China Conditionally Approves BeiGene's Sonrotoclax

1/7/2026Zai Lab Secures Second China Approval for Augtyro

1/7/2026Sanofi's Redemplo Wins China Approval for Rare Lipid Disorder FCS

1/7/2026ReviR Secures China CTN Clearance for FIC CMT Drug Candidate RTX-117

1/7/2026Shanghai ArkBio Secures China Approval for Aizhida in ADHD

1/7/2026GenEditBio Secures FDA IND Clearance for FIC In Vivo Genome Editing Ey...

1/7/2026GenHouse Pharma Advances MAT2A Inhibitor GH31 With China Trial Approva...

1/7/2026Epigenic Advances FIC Epigenetic HBV Therapy With U.S. IND Clearance

1/6/2026Insilico Medicine Signs $888 Million Oncology Drug Discovery Alliance ...

1/6/2026Ascletis Secures U.S. FDA IND Clearance for Phase II Study of ASC30

1/6/2026Merck's First-in-Class PAH Therapy Winrevair Secures China Approval

1/1/2026Akeso's Pempulimab Wins New Approval in China

1/1/2026J&J's Subcutaneous Amivantamab Regimen for EGFR-Mutant Lung Cancer App...

12/30/2025HUTCHMED's Fanregratinib NDA Granted Priority Review in China

12/30/2025Recbio's Files NDA for Shingles Vaccine REC610 China

12/30/2025China Rejects Tianmai Biotech's Oral Insulin Capsule ORMD-0801

12/30/2025AstraZeneca and Daiichi Sankyo Secures Chinese Approval of Enhertu fo...

12/30/2025Innovent's Ipilimumab IBI310 for Neoadjuvant Therapy approved in China

12/30/2025China Approves AstraZeneca and Ionis' Wainua for ATTRv-PN

12/30/2025Simcere Registers Phase 1 MRCT for EGFR/c-Met Bispecific ADC SIM0610 i...

Page:1/21 Total number of articles:629: [First][<<] [1] [2] [3] [4] [5] [>>] [End]